CD8A and neoplasm: The agonistic effect on a costimulatory immune receptor and antagonistic effect on a coinhibitory immune receptor induced by the dual antibody treatment were observed to have synergistic anti-tumoral outcomes mediated by the enhanced effector functions and tumor infiltration of CD4+ and CD8+ T cells (88, 89).